Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis

Clinical Cancer Research

Volumn 10, Issue 10, 2004, Pages 3291-3300

  Lu, Karen H ^a   Patterson, Andrea P ^a   Wang, Lin ^a   Marquez, Rebecca T ^a   Atkinson, Edward N ^a   Baggerly, Keith A ^a   Ramoth, Lance R ^a   Rosen, Daniel G ^a   Liu, Jinsong ^a   Hellstrom, Ingegerd ^b   Smith, David ^c   Hartmann, Lynn ^c   Fishman, David ^d   Berchuck, Andrew ^e   Schmandt, Rosemarie ^a   Whitaker, Regina ^e   Gershenson, David M ^a   Mills, Gordon B ^a   Bast Jr , Robert C ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

^c MAYO CLINIC   (United States)

^d NORTHWESTERN UNIVERSITY MEDICAL CENTER   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; CLAUDIN; CLAUDIN 3; GELATINASE A; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; INHIBIN; KALLIKREIN; KALLIKREIN 10; KALLIKREIN 6; MESOTHELIN; MUCIN 1; NOTCH3 RECEPTOR; OSTEOPONTIN; PROSTASIN; TETRANECTIN; TRANSCRIPTION FACTOR E2F; TUMOR MARKER; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADVANCED CANCER; ANALYTIC METHOD; ARTICLE; CANCER SCREENING; CANCER STAGING; CLINICAL ARTICLE; EPITHELIUM CELL; EXPRESSED SEQUENCE TAG; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; RECURSIVE DESCENT PARTITION ANALYSIS; STAINING; UPREGULATION;

CELL LINE, TUMOR; CELL LINEAGE; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GTP PHOSPHOHYDROLASES; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; OVARY; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 2542489234     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-03-0409     Document Type: Article

References (23)

1. Greenlee RT, Murray T, Bolden S, Wing PA. Cancer statistics, 2000. CA Cancer J Clin 2000;50:7-33.
2. American Cancer Society. Cancer Facts and Figures. Atlanta, GA: American Cancer Society; 2003.
3. Fishman DA, Bozorgi K. The scientific basis of early detection of epithelial ovarian cancer early detection program (NOCEDP). In: Stack MS, Fishman DA, editors. Ovarian cancer. Boston, MA: Kluwer Academic Publishers; 2002. p. 3-28.
4. Schwartz DR, Wu R, Kardia SL, et al. Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas. Cancer Res 2003;63:2913-22.
5. Schwartz DR, Kardia SL, Shedden KA, et al. Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Cancer Res 2002;62:4722-9.
6. Bast RC Jr, Urban N, Shridhar V, et al. Early detection of ovarian cancer: promise and reality. In: Stack, MS, Fishman DA, editors. Ovarian cancer: Boston, MA: Kluwer Academic Publishers; 2002. p. 61-97.
7. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 2002;98:31-6.
8. Hastie T, Tibshirani R, Friedman J. The elements of statistical learning. New York: Springer; 2001.
9. Venables WN, Ripley BD. Modern applied statistics with S-Plus. New York: Springer-Verlag; 1994.
10. Chambers JM, Hastie TJ. Statistical models in S. Pacific Grove; CA: S. Wadsworth and Brooks, 1992.
11. Hellstrom I, Raycraft J, Hayden-Ledbetter M, et al. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res 2003;63:3695-700.
12. Welsh JB, Zarrinkar PP, Sapinoso LM, et al. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci USA 2001;98(3):1176-81.
13. Schummer M, Ng WV, Bumgarner RE, et al. Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas. Gene (Amst) 2001;238(2):375-85.
14. Hough CD, Sherman-Baust CA, Pizer ES, et al. Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 2000;60(22):6281-7.
15. Mok SC, Chao J, Skates S, et al. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology. J Natl Cancer Inst (Bethesda) 2001;93(19):1458-64.
16. Su AI, Welsh JB, Sapinoso LM, et al. Molecular classification of human carcinomas by use of gene expression signatures Cancer Res 2001;61(20):7388-93.
17. Giordano TJ, Shedden KA, Schwartz DR, et al. Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am J Pathol 2001;159(4):1231-8.
18. Laufs U, Adam O, Strehlow K, et al. Down-regulation of Rac-1 GTPase by estrogen. J Biol Chem 2003;278(8):5956-62.
19. Rangel LB, Agarwal R, D'Souza T, et al. Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin Cancer Res 2003;9(7):2567-75.
20. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature (Lond) 2000;406(6797):747-52.
21. Kirchhoff C, Habben I, Ivell R, Krull N. A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors. Biol Reprod 1991;45(2):350-7.
22. Shridhar V, Lee J, Pandita A, et al. Genetic analysis of early-versus late-stage ovarian tumors. Cancer Res 2001;61(15):5895-904.
23. Scholler N, Fu N, Yang Y, et al. Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma. Proc Natl Acad Sci USA 1999;96(20):11531-6.